Literature DB >> 11573821

Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro.

J Kovár1, T Valenta, H Stýbrová.   

Abstract

We studied the sensitivity of tumor cells to the induction of apoptosis by iron deprivation. Iron deprivation was achieved by the employment of a defined iron-deficient culture medium. Mouse 38C13 cells and human Raji cells die within 48 and 96 h of incubation in iron-deficient medium, respectively. On the contrary, mouse EL4 cells and human HeLa cells are completely resistant to the induction of death under the same experimental arrangement. Deoxyribonucleic acid fragmentation analysis by agarose gel electrophoresis as well as flow cytometric analysis after propidium iodide staining detected in 38C13 and Raji cells, but not in EL4 and HeLa cells, changes characteristic to apoptosis. The 38C13 cells, sensitive to iron deprivation, also displayed a similar degree of sensitivity to apoptosis induction by thiol deprivation (achieved by 2-mercaptoethanol withdrawal from the culture medium) as well as by rotenone (50 nM), hydroxyurea (50 microM), methotrexate (20 nM), and doxorubicin (100 nM). Raji cells shared with 38C13 cells a sensitivity to rotenone, methotrexate, doxorubicin, and, to a certain degree, to hydroxyurea. However, Raji cells were completely resistant to thiol deprivation. EI4 and HeLa cells, resistant to iron deprivation, also displayed a greater degree of resistance to most of the other apoptotic stimuli than did their sensitive counterparts. We conclude that some tumor cells in vitro are sensitive to apoptosis induction by iron deprivation, while other tumor cells are resistant. All the tumors found to be sensitive to iron deprivation in this study (four cell lines) are of hematopoietic origin. The mechanism of resistance to apoptosis induction by iron deprivation differs from the mechanism of resistance to thiol deprivation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573821     DOI: 10.1290/1071-2690(2001)037<0450:DSOTCT>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  32 in total

1.  Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13.

Authors:  J Kovar; L L Stunz; B C Stewart; K Kriegerbeckova; R F Ashman; J D Kemp
Journal:  Pathobiology       Date:  1997       Impact factor: 4.342

Review 2.  Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor.

Authors:  J D Kemp
Journal:  Histol Histopathol       Date:  1997-01       Impact factor: 2.303

3.  Differential growth-inhibitory effects of gallium on B-lymphocyte lines in high versus low iron concentrations.

Authors:  J Kovar; P Seligman; E W Gelfand
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

4.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

5.  In vitro tumor growth inhibition by bispecific antibodies to human transferrin receptor and tumor-associated antigens is augmented by the iron chelator deferoxamine.

Authors:  S T Hsieh-Ma; T Shi; J Reeder; D B Ring
Journal:  Clin Immunol Immunopathol       Date:  1996-08

6.  Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells.

Authors:  A Leardi; M Caraglia; C Selleri; S Pepe; C Pizzi; R Notaro; A Fabbrocini; S De Lorenzo; M Musicò; A Abbruzzese; A R Bianco; P Tagliaferri
Journal:  Br J Haematol       Date:  1998-08       Impact factor: 6.998

7.  Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.

Authors:  J D Kemp; T Cardillo; B C Stewart; E Kehrberg; G Weiner; B Hedlund; P W Naumann
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

8.  Growth-stimulating effect of transferrin on a hybridoma cell line: relation to transferrin iron-transporting function.

Authors:  J Kovár; F Franĕk
Journal:  Exp Cell Res       Date:  1989-06       Impact factor: 3.905

9.  Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells.

Authors:  R U Haq; J P Wereley; C R Chitambar
Journal:  Exp Hematol       Date:  1995-05       Impact factor: 3.084

10.  Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.

Authors:  C R Chitambar; P Boon; J P Wereley
Journal:  Clin Cancer Res       Date:  1996-06       Impact factor: 12.531

View more
  10 in total

1.  Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.

Authors:  Jan Kovár; Marie Ehrlichová; Barbora Smejkalová; Ilaria Zanardi; Iwao Ojima; Ivan Gut
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

2.  Sensitivity of cells to apoptosis induced by iron deprivation can be reversibly changed by iron availability.

Authors:  M Koc; Z Nad'ová; J Kovár
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

3.  Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells.

Authors:  Jana Vobořilová; Vlasta Němcová-Fürstová; Jitka Neubauerová; Iwao Ojima; Ilaria Zanardi; Ivan Gut; Jan Kovář
Journal:  Invest New Drugs       Date:  2009-12-16       Impact factor: 3.850

4.  Bioactive constituents of Indigofera spicata.

Authors:  Lynette Bueno Pérez; Jie Li; Daniel D Lantvit; Li Pan; Tran Ngoc Ninh; Hee-Byung Chai; Djaja Djendoel Soejarto; Steven M Swanson; David M Lucas; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2013-07-30       Impact factor: 4.050

5.  Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells.

Authors:  J Truksa; J Kovár; T Valenta; M Ehrlichová; J Polák; P W Naumann
Journal:  Cell Prolif       Date:  2003-08       Impact factor: 6.831

Review 6.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

7.  High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines.

Authors:  Khuloud Bajbouj; Jasmin Shafarin; Mawieh Hamad
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

8.  Caspase-2 is involved in cell death induction by taxanes in breast cancer cells.

Authors:  Michael Jelínek; Kamila Balušíková; Dana Kopperová; Vlasta Nĕmcová-Fürstová; Jan Šrámek; Julie Fidlerová; Ilaria Zanardi; Iwao Ojima; Jan Kovář
Journal:  Cancer Cell Int       Date:  2013-05-15       Impact factor: 5.722

9.  SDF-1 chemokine signalling modulates the apoptotic responses to iron deprivation of clathrin-depleted DT40 cells.

Authors:  Alena Pance; Frank R Morrissey-Wettey; Helen Craig; Alison Downing; Richard Talbot; Antony P Jackson
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

10.  Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine.

Authors:  Kana Komoto; Takahiro Nomoto; Sjaikhurrizal El Muttaqien; Hiroyasu Takemoto; Makoto Matsui; Yutaka Miura; Nobuhiro Nishiyama
Journal:  Cancer Sci       Date:  2020-11-29       Impact factor: 6.518

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.